Daniëlle C.H. Jacobs

1.5k citations
4 papers · 1.0k · 1 hit paper · h-index 4

Impact in

  • Hematology top 2%
    • Multiple Myeloma Research and Treatments
  • Oncology top 5%
    • Peptidase Inhibition and Analysis
    • HER2/EGFR in Cancer Research
    • CAR-T cell therapy research

Papers in

Daniëlle C.H. Jacobs

4 papers receiving 997 citations

Daniëlle C.H. Jacobs's Hit Papers

Daratumumab, a Novel Therapeutic Human CD38 Monoclonal Antibody, Induces Killing of Multiple Myeloma and Other Hematological Tumors 2010 · 803 citations
8030+5+10Years since publication250500750

Peers

Daniëlle C.H. Jacobs
Comparison fields: 5 of 57
  • Hematology 568
  • Oncology 471
  • Physiology 78
  • Genetics 149
  • Radiology, Nuclear Medicine and Imaging 265
Replace Michael S. van der Veer with:
Michael S. van der Veer Netherlands
Jakub Krejcik Denmark
Marielle Chiron France
Thomas G. Martin United States
Nisha S. Joseph United States
Milada S. Vala United States
Shulamiet H. Wittebol Netherlands
Simon He Australia
Ann Mohrbacher United States
Andrea Freeman United States
Daniëlle C.H. Jacobs relative to Michael S. van der Veer Netherlands Michael S. van der Veer's profile →
Citations per field
00.5×1.5×
Michael S. van der Veer · 1×
Citations per year

Countries citing papers authored by Daniëlle C.H. Jacobs

Since Specialization
Citations

This map shows the geographic impact of Daniëlle C.H. Jacobs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniëlle C.H. Jacobs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniëlle C.H. Jacobs more than expected).

Fields of papers citing papers by Daniëlle C.H. Jacobs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniëlle C.H. Jacobs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniëlle C.H. Jacobs. The network helps show where Daniëlle C.H. Jacobs may publish in the future.

Co-authors

The 25 scholars most cited alongside Daniëlle C.H. Jacobs, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniëlle C.H. Jacobs Line = papers co-authored together Daniëlle C.H. Jacobs links everyone, so they are left out of the graph.

All Works

4 of 4 papers shown
#Work
1
Daratumumab, a Novel Therapeutic Human CD38 Monoclonal Antibody, Induces Killing of Multiple Myeloma and Other Hematological Tumors
Hit paper breakdown →
2010803
2 2015154
3 200356
4 200911

About Daniëlle C.H. Jacobs

Daniëlle C.H. Jacobs is a scholar working on Genetics, Radiology, Nuclear Medicine and Imaging, Hematology, Immunology and Allergy and Pathology and Forensic Medicine, having authored 4 papers that have together received 1.0k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (3 papers), Chronic Lymphocytic Leukemia Research (2 papers), Multiple Myeloma Research and Treatments (2 papers), Synthesis and Biological Evaluation (1 paper), Cell Adhesion Molecules Research (1 paper), Lymphoma Diagnosis and Treatment (1 paper), HER2/EGFR in Cancer Research (1 paper) and Acute Lymphoblastic Leukemia research (1 paper). The work is most often cited by research in Hematology (568 citations), Oncology (471 citations), Physiology (78 citations), Genetics (149 citations) and Radiology, Nuclear Medicine and Imaging (265 citations). Daniëlle C.H. Jacobs has collaborated with scholars based in Netherlands, United States and Poland. Frequent co-authors include Joost M. Bakker, Paul W.H.I. Parren, Jan G. J. van de Winkel, Wim K. Bleeker, Lukas A. Oomen, Yu‐Tzu Tai, Tom Vink, Kenneth Carl Anderson, Michel de Weers and Jerry W. Slootstra. Their work appears in journals such as Blood, Molecular Cancer Therapeutics and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact